Synthetic Studies toward GKK1032s
A solution of 26 (8.0 mg, 20 µmol) in CDCl3 (0.5 mL) was
allowed to stand at room temperature for 3 days to give 27 (6.1
mg, 76%) after purification by column chromatography (hexane-
18 µmol) in dry toluene (2.0 mL) in the presence of 2,6-di-tert-
butyl-4-methylphenol (BHT) (2.0 mg, 9.0 µmol) was heated at 120
°C in a sealed tube for 12 h. After cooling, the mixture was
concentrated in Vacuo to afford a residue, which was purified by
column chromatography (hexane-ethyl acetate, 40:1 f 8:1) to give
51 (3.2 mg, 46%) and 52 (1.4 mg, 20%).
1
ethyl acetate, 10:1 f 4:1). The H NMR spectrum of this sample
was identical with that recorded for compound 27.
A solution of 26 (10.2 mg, 25 µmol) in toluene (1.0 mL) was
heated at reflux for 3 h to provide 27 (8.2 mg, 80%) after
purification by column chromatography (hexane-ethyl acetate, 10:1
Compound 51: colorless oil; [R]20 +114.2 (c 0.32, CHCl3);
D
IR (neat) 667, 756, 862, 920, 999, 1036, 1045, 1068, 1099, 1157,
1
1211, 1230, 1255, 1325, 1375, 1435, 1454, 1732, 2925, 2949 cm-1
;
f 4:1). The H NMR spectrum of this sample was identical with
1H NMR (500 MHz, CDCl3) δ 0.62 (q, J ) 12.1 Hz, 1H), 0.75 (s,
3H), 0.88 (d, J ) 6.4 Hz, 3H), 0.93 (t, J ) 12.1 Hz, 1H), 0.97 (d,
J ) 6.6 Hz, 3H), 1.14 (t, J ) 6.0 Hz, 1H), 1.26 (s, 3H), 1.55-1.68
(m, 1H), 1.68-1.80 (m, 1H), 1.75-1.88 (m, 1H), 1.76 (s, 3H),
1.92 (dd, J ) 4.1, 12.1 Hz, 1H), 1.98 (d, J ) 12.0 Hz, 1H), 2.36
(dt, J ) 7.2, 12.0 Hz, 1H), 2.62 (d, J ) 12.0 Hz, 1H), 3.29 (s, 3H),
3.65 (s, 3H), 3.82 (dd, J ) 6.0, 7.2 Hz, 1H), 4.44 (d, J ) 5.9 Hz,
1H), 4.54 (d, J ) 5.9 Hz, 1H), 4.88 (s, 1H), 4.95 (dd, J ) 1.6, 17.2
Hz, 1H), 5.02 (dd, J ) 1.6, 10.4 Hz, 1H), 5.67 (dd, J ) 10.4, 17.2
Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 15.7, 20.6, 21.9, 22.8,
26.7, 28.1, 29.5, 42.9, 43.3, 43.4, 46.3, 48.5, 50.9, 51.9, 53.5, 56.0,
66.4, 80.0, 97.8, 114.0, 131.6, 135.3, 143.3, 174.0; HREIMS (m/z)
calcd for C24H38O4 (M+), 390.2770, found 390.2770.
that recorded for 27.
Procedure for IMDA Reaction of Tetraene 26: (1′S,2′S,4a′S,
4b′S,8a′R,9′R,9a′S)-9′-Hydroxy-1′-methoxycarbonyl-2′,4′,4b′-tri-
methyl-2′-vinyl-spiro[1,3-dithiane-2,7′-2′,4a′,4b′,5′,6′,7′,8′,8a′,9′,
9a′-decahydro-1H-fluorene] (6) and (1′R,2′RS,3′S,3a′S,7a′R)-1′-
Hydroxy-2′-(2-methoxycarbonyl)methyl-3a′-methyl-3′-[(E)-4-
methylhexa-1,3,5-trien-2-yl]-spiro[1,3-dithiane-2,6′-octahydro-
1H-indene (31). A solution of tetraene 8 (14 mg, 23 µmol) in dry
toluene (3.0 mL) in the presence of 2,6-di-tert-butyl-4-methylphenol
(BHT) (2.5 mg, 12 µmol) was heated at 120 °C in a sealed tube
for 24 h. After cooling, the mixture was concentrated in vacuo to
give a residue, which was purified by column chromatography
(hexane-ethyl acetate, 20:1 f 5:1) to furnish 6 (8.5 mg, 61%)
and 31 (1.8 mg, 13%).
Compound 52: colorless oil; [R]20 +43.2 (c 0.14, CHCl3); IR
D
Compound 6: colorless needles (recrystallization from hexane-
(neat) 733, 877, 899, 1036, 1105, 1138, 1157, 1167, 1192, 1246,
Et2O); mp 163-166 °C; [R]20 +65.7 (c 0.85, CHCl3); IR (neat)
1
1259, 1383, 1435, 1454, 1736, 2908, 2922, 2949 cm-1; H NMR
D
607, 621, 688, 783, 804, 852, 908, 995, 1047, 1159, 1223, 1259,
(500 MHz, CDCl3) δ 0.50-0.64 (m, 1H), 0.68-0.78 (m, 1H), 0.85
(d, J ) 6.1 Hz, 3H), 0.89 (s, 3H), 0.94 (d, J ) 6.2 Hz, 3H), 1.03
(t, J ) 10.0 Hz, 1H), 1.60-1.78 (m, 4H), 1.87 (s, 3H), 2.55 (d, J
) 9.6 Hz, 1H), 2.55-2.67 (m, 2H), 2.71-2.80 (m, 1H), 3.35 (s,
3H), 3.53 (dd, J ) 4.4, 10.0 Hz, 1H), 3.56 (s, 3H), 4.61 (d, J ) 6.9
Hz, 1H), 4.71 (d, J ) 6.9 Hz, 1H), 5.04 (d, J ) 10.9 Hz, 1H), 5.04
(s, 1H), 5.17 (d, J ) 17.3 Hz, 1H), 5.26 (s, 1H), 5.83 (s, 1H), 6.38
(dd, J ) 10.9, 17.3 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 13.3,
16.7, 20.5, 22.6, 27.6, 30.1, 37.8, 43.4, 44.4, 45.8, 47.7, 51.4, 56.1,
57.8, 60.9, 88.8, 96.6, 112.6, 117.9, 134.8, 135.2, 142.1, 142.8,
173.6; HREIMS (m/z) calcd for C24H38O4 (M+), 390.2770, found
390.2761.
1
1331, 1375, 1435, 1716, 2875, 2931, 3500 cm-1; H NMR (500
MHz, CDCl3) δ 0.79 (s, 3H), 1.28 (s, 3H), 1.42-1.53 (m, 1H),
1.69-1.83 (m, 3H), 1.75 (s, 3H), 1.89-2.00 (m, 3H), 2.00-2.10
(m, 2H), 2.11-2.18 (m, 1H), 2.33 (dt, J ) 8.3, 12.0 Hz, 1H), 2.52
(dt, J ) 13.4, 2.2 Hz, 1H), 2.61 (d, J ) 12.0 Hz, 1H), 2.65-2.75
(m, 1H), 2.77-2.87 (m, 2H), 2.95-3.03 (m, 1H), 3.68 (s, 3H),
3.93-3.99 (m, 1H), 4.85 (s, 1H), 4.98 (dd, J ) 1.5, 17.2 Hz, 1H),
5.05 (dd, J ) 1.5, 10.4 Hz, 1H), 5.69 (dd, J ) 10.4, 17.2 Hz, 1H);
13C NMR (125 MHz, CDCl3) δ 13.3, 21.2, 25.9, 26.1, 26.4, 26.7,
34.5, 35.0, 35.3, 41.3, 42.4, 44.0, 50.3, 51.3, 52.3, 54.4, 55.5, 72.7,
114.5, 131.3, 135.4, 142.8, 174.8; HREIMS (m/z) calcd for
C23H34O3S2 (M+), 422.1949, found 422.1950.
(b) Under Lewis Acid Conditions. Diethylaluminum chloride
in hexane (0.87 M solution, 52 mL, 46 µmol) was added slowly to
a stirred solution of 32 (8.9 mg, 23 µmol) in dry toluene (2.5 mL)
at -40 °C under argon. After 2 h, the reaction was quenched with
15% aqueous Rochelle salt (8 mL) at -40 °C, and the resulting
mixture was extracted with ethyl acetate (3 × 10 mL). The
combined extracts were washed with 3% aqueous HCl (2 × 6 mL),
saturated aqueous NaHCO3 (2 × 6 mL), and brine (2 × 6 mL),
andthen dried over MgSO4. Concentration of the solvent in vacuo
afforded a residue, which was purified by column chromatography
(hexane-ethyl acetate, 30:1 f 10:1) to give 51 (7.0 mg, 76%) as
Compound 31: pale yellow oil; [R]20 +25.6 (c 0.18, CHCl3);
D
IR (neat) 667, 752, 901, 989, 1174, 1205, 1236, 1255, 1277, 1331,
1340, 1379, 1415, 1437, 1601, 1622, 1720, 2925, 2949, 3948 cm-1
;
1H NMR (500 MHz, CDCl3) δ 0.93 (s, 1/3H), 0.93 (s, 2/3 × 3H),
1.55-1.70 (m, 1H), 1.70-1.90 (m, 3H), 1.87 (s, 1/3H), 1.91 (s,
2/3H), 1.88-1.99 (m, 2H), 1.97-2.10 (m, 3H), 2.35-2.48 (m, 2H),
2.56-2.73 (m, 3H), 2.74-2.83 (m, 1H), 2.85-2.95 (m, 1H), 3.01-
3.10 (m, 1H), 3.55 (d, J ) 2.1 Hz, 1/3H), 3.58 (d, J ) 2.0 Hz,
2/3H), 3.57-3.67 (m, 1H), 3.68 (s, 3H), 5.02 (s, 1/3H), 5.05 (s,
2/3H), 5.08 (d, J ) 10.7 Hz, 2/3H), 5.12 (d, J ) 10.9 Hz, 1/3H),
5.18 (s, 1/3H), 5.21 (s, 2/3H), 5.21 (d, J ) 17.4 Hz, 2/3H), 5.28
(d, J ) 17.4 Hz, 1/3H), 5.76 (br s, 1/3H), 5.80 (br s, 2/3H), 6.37
(dd, J ) 10.7, 17.4 Hz, 2/3 × 1H), 6.92 (dd, J ) 10.9, 17.4 Hz,
1/3H); 13C NMR (125 MHz, CDCl3) δ 13.4 (2/3C), 13.6 (1/3C),
16.1 (2/3C), 16.2 (1/3C), 17.5 (1/3C), 20.3 (2/3C), 25.9 (2/3C),
26.0 (2/3C), 26.4 (2/3C), 26.9 (1/3C), 27.9 (1/3C), 29.7 (1/3C),
34.3, 34.7, 37.3 (2/3C), 37.4 (1/3C), 42.8, 45.4 (2/3C), 45.5 (1/
3C), 50.1, 50.5 (1/3C), 50.6 (2/3C), 51.9, 57.3 (1/3C), 57.5 (2/
3C), 80.0, 113.2 (2/3C), 114.8 (1/3C), 118.1 (2/3C), 119.1 (1/3C),
133.2 (1/3C), 134.7 (2/3C), 135.1 (1/3C), 135.4 (2/3C), 141.7,
142.4, 175.6; HREIMS (m/z) calcd for C23H34O3S2 (M+), 422.1949,
found 422.1951.
a colorless oil; [R]20 +114.8 (c 0.70, CHCl3). The 1H NMR
D
spectrum of this sample were identical with those described in (a).
Acknowledgment. We are grateful to Dr. T. Mori (Tokyo
Institute of Technology) for his assistance in MS spectra
measurements. This work was supported in part by Grants-in-
Aid for Scientific Research on Priority Areas (no. 17035073)
and for High Technology Research Program from the Ministry
of Education, Culture, Sports, Science and Technology of Japan.
Supporting Information Available: Experimental procedures
and spectroscopic and analytical data for all other new compounds.
Copies of 1H and 13C NMR spectra for all new compounds. X-ray
crystallographic information for 39a in CIF format. This material
Procedure for IMDA Reaction of Tetraene 32: (1R,2S,4aS,
4bS,6R,8S,8aR,9R,9aS)-9- Methoxymethoxy-2,4,4b,6,8-penta-
methyl-2-vinyl-2,4a,4b,5,6,7,8,8a,9,9a-decahydro-1H-fluorene-1-
carboxylic acid methyl ester (51) and [(1R,2S,3S,3aS,5R,7S,
7aR)-1-Methoxymethoxy-3a,5,7- trimethyl-3-[(E)-4-methylhexa-
1,3,5-trien-2-yl]octahydro-1H-inden-2-yl]acetic acid methyl ester
(52). (a) Under Thermal Conditions. A solution of 32 (7.0 mg,
JO0610208
J. Org. Chem, Vol. 71, No. 18, 2006 6951